ロード中...
Antibodies against p53 protein in serum of patients with benign or malignant pancreatic and biliary diseases.
Specific markers for pancreatic or biliary cancer have been developed in the past few years. Ca 19-9 has a good sensitivity but it is also increased in benign cholestasis. Mutations in the p53 gene are commonly reported in pancreatic cancer and can be detected by a serological analysis. The aim of t...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1995
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1382465/ https://ncbi.nlm.nih.gov/pubmed/7698709 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|